BE691159A - - Google Patents

Info

Publication number
BE691159A
BE691159A BE691159DA BE691159A BE 691159 A BE691159 A BE 691159A BE 691159D A BE691159D A BE 691159DA BE 691159 A BE691159 A BE 691159A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE691159A publication Critical patent/BE691159A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE691159D 1962-02-15 1966-12-14 BE691159A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1962S0078054 DE1236523C2 (de) 1962-02-15 1962-02-15 Verfahren zur herstellung von basischen phenylaethern und deren salzen
US442476A US3309406A (en) 1962-02-15 1965-03-24 1-t-butylamino-3-phenoxy-2-propanols

Publications (1)

Publication Number Publication Date
BE691159A true BE691159A (en:Method) 1967-05-16

Family

ID=25996774

Family Applications (1)

Application Number Title Priority Date Filing Date
BE691159D BE691159A (en:Method) 1962-02-15 1966-12-14

Country Status (6)

Country Link
US (1) US3309406A (en:Method)
BE (1) BE691159A (en:Method)
DE (1) DE1236523C2 (en:Method)
FR (1) FR5829M (en:Method)
GB (1) GB1147032A (en:Method)
NL (1) NL154722B (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128052A (en) * 1965-06-08 1968-09-25 Ici Ltd Alkanolamine derivatives
US3954227A (en) * 1969-11-28 1976-05-04 Teikoku Hormone Mfg. Co., Ltd. Pharmaceutical compositions containing 1-(2',3'-dimethylphenoxy)-3-tert. butylamino-2-propanol or pharmaceutically acceptable salt thereof for treating or preventing coronary disorders
FR2121447A2 (en) * 1971-01-14 1972-08-25 Rech Pharmaceut Scien Beta-adrenergic blocking aryloxy-prop - anolamines
FR2077774A1 (en) * 1970-02-13 1971-11-05 Rech Pharmac Scien Beta-adrenergic blocking aryloxy-prop - anolamines
GB1312055A (en) * 1970-04-20 1973-04-04 Ici Ltd Alkanolamine derivatives
CH569692A5 (en:Method) * 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US3917678A (en) * 1972-01-25 1975-11-04 Squibb & Sons Inc Organic acid salts of 1-{8 0-{8 (3-dimethylaminopropyl)thio{9 phenyl{9 -3-methylurea
FR2192812A1 (en) * 1972-07-20 1974-02-15 Centre Etd Ind Pharma 2-(3-Amino 2-hydroxy propoxy) thymotic acid cpds - with local anaesth-etic, anti arrhythmic and antitussive activity
DE2935901C2 (de) * 1979-09-05 1983-06-01 A. Nattermann & Cie GmbH, 5000 Köln 1-(2-Acetylphenylthio)-3-alkylamino-2-propanole und deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
TW275614B (en:Method) * 1993-02-15 1996-05-11 Senju Pharma Co
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
FR3030514A1 (fr) * 2014-12-18 2016-06-24 Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) Dimeres polyaromatiques
SI3911648T1 (sl) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1S,3S)-3-[[5-(difluorometoksi)-2-pyrimidinil]amino]ciklopentil]amino][1(2H),3'-bipiridin]-2-on kot zaviralec PCSK9 in postopki njegove uporabe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB622297A (en) * 1946-12-06 1949-04-29 British Drug Houses Ltd Improvements in or relating to the preparation of basic ethers
US3033640A (en) * 1954-06-16 1962-05-08 Saul & Co Incorporation of an organic basic compound into cellulose acetate materials
DE1220440B (de) * 1962-02-14 1966-07-07 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen

Also Published As

Publication number Publication date
DE1236523C2 (de) 1975-06-12
NL6618113A (en:Method) 1968-06-24
NL154722B (nl) 1977-10-17
US3309406A (en) 1967-03-14
DE1236523B (de) 1967-03-16
GB1147032A (en) 1969-04-02
FR5829M (en:Method) 1968-02-26

Similar Documents

Publication Publication Date Title
FR5829M (en:Method)
FI45264B (en:Method)
FR3839M (en:Method)
FI41173B (en:Method)
FR1589356A (en:Method)
FR1317657A (en:Method)
FI42042B (en:Method)
BE621305A (en:Method)
BE620787A (en:Method)
BE683774A (en:Method)
BE640558A (en:Method)
BE640183A (en:Method)
BE640152A (en:Method)
BE639034A (en:Method)
BE637964A (en:Method)
BE632501A (en:Method)
BE632074A (en:Method)
BE630170A (en:Method)
BE624224A (en:Method)
BE621473A (en:Method)
BE621469A (en:Method)
BE621370A (en:Method)
BE626963A (en:Method)
BE621105A (en:Method)
BE620937A (en:Method)